EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Xanthine oxidase inhibitory kinetics and mechanism of ellagic acid: In vitro, in silico and in vivo studies

Jianmin Chen iD, Zemin He, Sijin Yu, Xiaozhen Cai, Danhong Zhu, Yanhua Lin

IET Nanobiotechnology · 2023-06 · 17 (4) · 368-375

DOI: 10.1049/nbt2.12135 ↗

Kurz gefasst

Fachartikel in der Zeitschrift IET Nanobiotechnology, online erschienen am 08.05.2023. Verfasst von Jianmin Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Putian University, Putian, Fujian, China. Hauptthemen laut MEDLINE: Allopurinol, Hyperuricemia. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Putian Science and Technology Bureau, National Natural Science Foundation of China, University Student's Innovations Special Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ellagic acid (EA), which is widely distributed in many foods, has been found to possess inhibitory activity against xanthine oxidase (XO). However, there is ongoing debate about the difference in XO inhibitory activity between EA and allopurinol. Additionally, the inhibitory kinetics and mechanism of EA on XO are still unclear. Herein, the authors systematically studied the inhibitory effects of EA on XO. The authors’ findings showed that EA is a reversible inhibitor with mixed‐type inhibition, and its inhibitory activity is weaker than allopurinol. Fluorescence quenching experiments suggested that the generation of EA‐XO complex was exothermic and spontaneous. In silico analysis further confirmed that EA entered the XO catalytic centre. Furthermore, the authors verified the anti‐hyperuricemia effect of EA in vivo. This study elucidates the inhibition kinetics and mechanism of EA on XO, and lays a theoretical foundation for the further development of drugs and functional foods containing EA for the treatment of hyperuricemia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AllopurinolHyperuricemiaHumansEnzyme InhibitorsXanthine OxidaseEllagic AcidKinetics

Stichwörter der Autor:innen

biochemistrybiological techniquesdrugsenzymes

Substanzen

AllopurinolEnzyme InhibitorsXanthine OxidaseEllagic Acid

Autor:innen und Institutionen

  • School of Pharmacy, Putian University, Putian, Fujian, China.
  • Key Laboratory of Pharmaceutical Analysis and Laboratory Medicine (Putian University), Fujian Province University, Putian, Fujian, China.

ORCID-Profile: Jianmin Chen

Förderung

  • Putian Science and Technology Bureau
  • National Natural Science Foundation of China
  • University Student's Innovations Special Project

Zitieren

APA

Chen, J., He, Z., Yu, S., Cai, X., Zhu, D., & Lin, Y. (2023). Xanthine oxidase inhibitory kinetics and mechanism of ellagic acid: In vitro, in silico and in vivo studies. IET Nanobiotechnology, 17(4), 368-375. https://doi.org/10.1049/nbt2.12135

Vancouver

Chen J, He Z, Yu S, Cai X, Zhu D, Lin Y. Xanthine oxidase inhibitory kinetics and mechanism of ellagic acid: In vitro, in silico and in vivo studies. IET Nanobiotechnology. 2023;17(4):368-375. doi:10.1049/nbt2.12135

BibTeX
@article{Chen2023,
  author = {Chen, Jianmin and He, Zemin and Yu, Sijin and Cai, Xiaozhen and Zhu, Danhong and Lin, Yanhua},
  title = {Xanthine oxidase inhibitory kinetics and mechanism of ellagic acid: In vitro, in silico and in vivo studies},
  journal = {IET Nanobiotechnology},
  year = {2023},
  volume = {17},
  number = {4},
  pages = {368--375},
  doi = {10.1049/nbt2.12135}
}
Kostenlos starten →